John Pappajohn, Director, 10% Owner at CANCER GENETICS, INC (CGIX), bought 86,185 shares at $3.28 ($280K) on 2017-08-18, disclosed to the SEC on 2017-08-18.
Open-market purchase of $280k CGIX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.24 | 66,185 | $214K | 76.6% |
| 2 | $3.28 | 20,000 | $66K | 23.4% |
| Total | $3.25 avg | 86,185 | $280K | 100% |
| Filing → |
| CGIX | BUY | 2019-02-01 | $230K | — | Filing → |
| CGIX | BUY | 2019-01-16 | $230K | — | Filing → |
| MYND | BUY | 2018-08-28 | $163K | — | Filing → |